Asahi Life Asset Management Co., Ltd.
Source: SEC Form 13F · as of Mar 2026Asahi Life Asset Management Co., Ltd. holds 14 biotech & pharma companies tracked by BioSniper, totaling $16.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$16.0M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 9,868 | $3.5M |
| JNJJOHNSON & JOHNSON | 11,957 | $2.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,417 | $2.5M |
| MRKMerck & Co., Inc. | 12,158 | $1.5M |
| LLYELI LILLY & Co | 1,361 | $1.3M |
| ABBVAbbVie Inc. | 4,449 | $968K |
| PMPhilip Morris International Inc | 4,529 | $749K |
| PFEPFIZER INC | 21,579 | $606K |
| GMOptec International, Inc. | 5,684 | $423K |
| RPRXRoyalty Pharma plc | 7,566 | $363K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,083 | $358K |
| ZBHZimmer Biomet Holdings Inc. | 3,506 | $317K |
| ABTABBOTT LABORATORIES | 2,927 | $301K |
| GILDGILEAD SCIENCES, INC. | 2,062 | $287K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.